immunity News and Research

RSS

RSV vaccines for older adults: 2023 ACIP recommendations

A recent report published in Morbidity and Mortality Weekly Report provided clinical guidance on Respiratory syncytial virus (RSV) vaccines for adults ≥60 years.

1 Aug 2023

The microbiota connection, gut health linked to metabolic syndrome prevalence

The relationship between gut microbiota and metabolic disorders focused on BA metabolism and immunity.

1 Aug 2023

Study offers new insight into how antimicrobial resistance emerges in patients with bacterial infections

A research study led by the University of Oxford provides a transformational new insight into how antimicrobial resistance (AMR) emerges in patients with bacterial infections.

31 Jul 2023

Tulane study finds potential treatment for eosinophilic esophagitis

A new study from Tulane University has identified a new treatment for a chronic immune system disease that can prevent children from eating.

31 Jul 2023

Study illuminates new connections between diet and immunity

A metabolic by-product that is more prevalent during fasting may supercharge immune cells as they fight infection and disease, reports an early stage study by Van Andel Institute scientists and collaborators.

28 Jul 2023

RNF41 protein could be a new therapeutic target against cirrhosis and liver inflammation

The RNF41 protein could be a new therapeutic target in the fight against two chronic liver diseases: cirrhosis and liver inflammation.

28 Jul 2023

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

Study investigated if patients with systemic autoimmune rheumatic diseases (SARDs) have a reduced immunological response.

27 Jul 2023

Study highlights need for integration of policy, behavior change, and risk communication in pandemic response

Researchers measured the association between reproduction number, a weekly measure of real-time severe acute respiratory syndrome coronavirus 2.

27 Jul 2023

Japanese researchers identify genetic quirk linked to severe COVID-19

Despite intensive research since the pandemic began, much remains unknown about COVID-19, particularly why it can be so severe in some cases and relatively mild in others.

25 Jul 2023

Third dose COVID-19 booster vaccines offer lasting protection, trial shows

Third dose COVID-19 booster vaccines offer lasting protection after several months, according to the latest results of a nationwide trial.

25 Jul 2023

Characterizing the concentration and binding affinity of WT–induced antibodies against the Omicron subvariant BA.1

A recent study characterized the concentration and binding affinity of antibodies induced by SARS-CoV-2 WT strain against the Omicron subvariant BA.1.

25 Jul 2023

Unlocking the secrets of asymptomatic COVID-19 infections: HLA-B*15:01 connection revealed

Researchers describe the findings of the COVID-19 Citizen Science Study.

25 Jul 2023

Arming phages with heterologous effectors paves the way for successful UTI treatment

Study demonstrated how phage can be engineered to produce bacteriocins and cell wall hydrolases as antimicrobial effector genes.

24 Jul 2023

Research reveals therapeutic potential of novel compound in inhibiting oncogene translation

Cutting-edge research at the Luxembourg Institute of Health reveals the ground-breaking therapeutic potential of the compound FL3 in inhibiting oncogene translation and rewiring cancer cell metabolism, opening up new therapeutic opportunities for leukemia patients.

24 Jul 2023

Scripps Research scientists develop AI tool to track the detailed evolution of viral pandemics

Scripps Research scientists have developed a machine-learning system-;a type of artificial intelligence (AI) application-;that can track the detailed evolution of epidemic viruses and predict the emergence of viral variants with important new properties.

21 Jul 2023

immunity News and Research

RSV vaccines for older adults: 2023 ACIP recommendations

The microbiota connection, gut health linked to metabolic syndrome prevalence

Study offers new insight into how antimicrobial resistance emerges in patients with bacterial infections

Tulane study finds potential treatment for eosinophilic esophagitis

Study illuminates new connections between diet and immunity

RNF41 protein could be a new therapeutic target against cirrhosis and liver inflammation

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

Study highlights need for integration of policy, behavior change, and risk communication in pandemic response

Japanese researchers identify genetic quirk linked to severe COVID-19

Third dose COVID-19 booster vaccines offer lasting protection, trial shows

Characterizing the concentration and binding affinity of WT–induced antibodies against the Omicron subvariant BA.1

Unlocking the secrets of asymptomatic COVID-19 infections: HLA-B*15:01 connection revealed

Arming phages with heterologous effectors paves the way for successful UTI treatment

Research reveals therapeutic potential of novel compound in inhibiting oncogene translation

Scripps Research scientists develop AI tool to track the detailed evolution of viral pandemics

Flu and COVID-19 report offers latest surveillance data and public health advice

A model-based approach to estimating vaccine effectiveness against SARS-CoV-2 variants of concern

Pertussis vaccination responses in COPD patients

Advancing vaccine adjuvants: exploring cutting-edge platforms for improved immunization

Immune boosting model overcomes the limitations of the leaky and polarized vaccination models

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News